# Filing Detail

Form 424B4 - Prospectus [Rule 424(b)(4)]:
SEC Accession No. 0001047469-18-005126
Filing Date
2018-07-23
Accepted
2018-07-23 16:58:38
Documents
9

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 424B4 | a2236275z424b4.htm | 424B4 | 2268778
2 | G70635.JPG | g70635.jpg | GRAPHIC | 15448
3 | G695148.JPG | g695148.jpg | GRAPHIC | 116510
4 | G846377.JPG | g846377.jpg | GRAPHIC | 85700
5 | G139148.JPG | g139148.jpg | GRAPHIC | 90545
6 | G904926.JPG | g904926.jpg | GRAPHIC | 70849
7 | G163379.JPG | g163379.jpg | GRAPHIC | 62238
8 | G251911.JPG | g251911.jpg | GRAPHIC | 54147
9 | G741581.JPG | g741581.jpg | GRAPHIC | 128267
| Complete submission text file | 0001047469-18-005126.txt |  | 3129920

Mailing Address 18 COMMERCE WAY WOBURN MA 01801
Business Address 18 COMMERCE WAY WOBURN MA 01801 781-995-2443
Replimune Group, Inc. (Filer) CIK: 0001737953 (see all company filings)

EIN.: 822082553 | State of Incorp.: MA | Fiscal Year End: 0331
Type: 424B4 | Act: 33 | File No.: 333-225846 | Film No.: 18964979
SIC: 2836 Biological Products, (No Diagnostic Substances)